Why inventing a vaccine for AIDS is tougher than for COVID

By NPR
| January 26, 2023

The four-decades long effort to create an HIV vaccine suffered a blow last week with news that Janssen Pharmaceuticals was discontinuing the only current late-stage clinical trial of a vaccine. Results showed it to be ineffective.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...